Deubiquitinating enzymes-mediated post-translational modifications of ferroptosis regulates cancer drug resistance
Lili Zhang, Ming Li, Yumin Wang, Huiyan Sun, Hao Lian · 2026
Read Deubiquitinating enzymes-mediated post-translational modifications of ferroptosis regulates cancer drug resistance by Lili Zhang, Ming Li, Yumin Wang, Huiyan Sun, Hao Lian (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13550395.txt.
Description
Lili Zhang and colleagues review how enzymes that strip ubiquitin tags from proteins govern ferroptosis, an iron-fueled cell death, and thereby steer cancer drug resistance, in a 2026 article. Resistant tumors often lean hard on their defenses against ferroptosis, whose core regulators are controlled by how long the proteins survive and where they sit in the cell. Deubiquitinating enzymes edit those fates.
The review maps which enzymes stabilize or doom each ferroptosis regulator. Some act through disposal by the proteasome or lysosome. Others change activity directly. It then gathers evidence tying these ubiquitin edits to resistance against chemotherapy, targeted drugs, and immunotherapy. The authors close with strategies for attacking the ubiquitin and ferroptosis axis to wake stubborn tumors back up to drugs. Forcing this distinctive death, they argue, could crack resistance that blocks the usual routes.
Catalog record
| CREATOR | Lili Zhang, Ming Li, Yumin Wang, Huiyan Sun, Hao Lian |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 86687 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |